Full-Time

Market Strategy Lead

Life Sciences

Confirmed live in the last 24 hours

Analog Devices

Analog Devices

10,001+ employees

Designs and manufactures high-performance semiconductors

Compensation Overview

$125.3k - $187.9k/yr

+ Bonus

Senior

Boston, MA, USA

In Person

10% travel required.

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • PhD in Biology, Biological or Biomedical Engineering or a related field, or Masters with equivalent work experience
  • Minimum 5 years post-graduate and/or industrial experience working in product development or marketing for life science tools
  • Technical background in Life Sciences with hands-on knowledge in one or more of the following: High throughput screening (HTS), in vitro Cell and Molecular assays, protein or biophysics assays, biomanufacturing
  • Strong understanding of the drug discovery pipeline including the challenges and opportunities for advancing the industry
  • Research experience biotech or pharma – including drug discovery, development, or biomanufacturing
  • Strong collaborative skills and the ability to work effectively in a fast-paced multidisciplinary team environment
  • Experience working closely with quantitative biology, computational biology, or other data analysis teams
  • Experience assessing biopharmaceutical competitive landscape
  • Demonstrated experience in startups, tech incubators, advanced-technology groups, or other entrepreneurial settings, with a track record of driving creative ideas from concept to prototype or market launch
Responsibilities
  • Staying updated on industry trends and advancements
  • Researching industry, technology and application trends and distilling and sharing out this information to a diverse audience
  • Assessing the competitive landscape across the Biopharma research tools landscape and how it is evolving
  • Building internal tools for coordination and sharing of market and area expertise
  • Building new approaches to share distilled market challenges, and drive collaborative cross-team, and cross-functional efforts to integrate creative ideas from diverse teams
  • Conducting customer discovery to understand emerging customer needs and how we could address future markets
  • Fostering a culture of creativity and entrepreneurial thinking—drawing on lean-startup and incubator best practices—to spark novel concepts and rapid experimentation
  • Understanding our technical capabilities and envisioning future industry scenarios with the team to identify where we can build breakthrough solutions for upcoming challenges
  • Advising the technical team on critical areas for new technology development to expand our digital biology platform that could unlock groundbreaking new product areas
  • Sustaining close collaborations across Analog Devices' business units and with external partners
  • Envisioning and outlining potential go-to-market strategy for potential program areas

Analog Devices designs and manufactures a wide range of semiconductor products, including analog, mixed-signal, and digital signal processing integrated circuits. These products are essential for sensing, measuring, interpreting, connecting, and powering various electronic devices. ADI's components are used in many industries such as industrial, automotive, communications, and consumer markets, and are integrated into the products of original equipment manufacturers (OEMs). Unlike many competitors, ADI focuses on high-performance solutions that address complex engineering challenges, fostering strong relationships with its customers. The company's goal is to bridge the physical and digital worlds through its advanced semiconductor technologies.

Company Size

10,001+

Company Stage

IPO

Headquarters

Wilmington, Massachusetts

Founded

1965

Simplify Jobs

Simplify's Take

What believers are saying

  • ADI's €630 million Limerick investment boosts European semiconductor manufacturing.
  • Growing demand for GaN technology enhances ADI's power conversion solutions.
  • MEMS technology expansion supports healthcare applications like hearing aids.

What critics are saying

  • Emerging Asian semiconductor firms threaten ADI's market share.
  • Global chip shortage may disrupt ADI's supply chain.
  • Rising interest rates could limit ADI's financial flexibility.

What makes Analog Devices unique

  • ADI offers high-performance analog and mixed-signal ICs for diverse industries.
  • The company bridges physical and digital domains with its semiconductor solutions.
  • ADI's strong OEM relationships help solve complex engineering challenges.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Holidays

Paid Sick Leave

Company News

Simply Wall St
Jun 30th, 2025
Will $1.5 Billion Bond Offering Change Analog Devices' (ADI) Narrative?

Analog Devices completed two major fixed-income offerings, raising approximately US$1.50 billion through the issuance of callable senior unsecured notes maturing in 2028 and 2030 at fixed coupons of 4.25% and 4.5%, respectively.

PR Newswire
May 23rd, 2025
Analog Devices to Participate in Bernstein Strategic Decisions Conference

Analog Devices to participate in Bernstein Strategic Decisions Conference.

Keekli
May 22nd, 2025
Ashwini Vaishnaw Calls for Unified Industry-Academia Action to Drive Workforce Readiness for Viksit Bharat 2047

NAMTECH has also partnered with Siemens India, Analog Devices Inc., and Applied Materials Inc. to develop infrastructure, training labs, and scholarship programs in key sectors like semiconductors, robotics, and advanced manufacturing.

PR Newswire
May 22nd, 2025
Analog Devices Reports Fiscal Second Quarter 2025 Financial Results

Revenue of $2.64 billion, with double-digit year-over-year growth across all end markets. Operating cash flow of $3.9 billion and free cash flow of $3.3 billion on a trailing twelve-month basis or 39% and 34% of revenue, respectively. Returned $0.7 billion to shareholders via dividends and repurchases during the second quarterWILMINGTON, Mass., May 22, 2025 /PRNewswire/ -- Analog Devices, Inc. (Nasdaq: ADI), a global semiconductor leader, today announced financial results for its fiscal second quarter 2025, which ended May 3, 2025

EE Journal
May 16th, 2025
Latest GaN half-bridge drivers for power conversion and motion control in consumer and industrial applications

WILMINGTON, Mass. - Analog Devices, Inc. (ADI) today announced a three-axis MEMS accelerometer designed for a wide range of healthcare and industrial applications, including vital signs monitoring, hearing aids, and motion-enabled metering devices.